CHARLES SCHWAB INVESTMENT MANAGEMENT INC - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 152 filers reported holding AKERO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.85 and the average weighting 0.6%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$21,214,769
+54.2%
419,430
+42.3%
0.01%
+50.0%
Q2 2023$13,757,769
+50.9%
294,662
+23.6%
0.00%
+33.3%
Q1 2023$9,119,156
-29.7%
238,347
+0.7%
0.00%
-25.0%
Q4 2022$12,965,516
+78.7%
236,597
+11.1%
0.00%
+33.3%
Q3 2022$7,254,000
+365.6%
213,019
+29.2%
0.00%
+200.0%
Q2 2022$1,558,000
-36.7%
164,823
-5.0%
0.00%0.0%
Q1 2022$2,463,000
-33.2%
173,546
-0.4%
0.00%0.0%
Q4 2021$3,686,000
-0.3%
174,252
+5.4%
0.00%0.0%
Q3 2021$3,696,000
+7.2%
165,353
+19.0%
0.00%0.0%
Q2 2021$3,449,000
+7.0%
138,993
+25.1%
0.00%0.0%
Q1 2021$3,224,000
+15.8%
111,111
+2.9%
0.00%0.0%
Q4 2020$2,785,000
-16.1%
107,932
+0.1%
0.00%
-50.0%
Q3 2020$3,320,000
+161.4%
107,813
+111.6%
0.00%
+100.0%
Q2 2020$1,270,000
+35.1%
50,945
+14.9%
0.00%0.0%
Q1 2020$940,000
+16.9%
44,326
+22.4%
0.00%
Q4 2019$804,000
+9.4%
36,224
+12.2%
0.00%
Q3 2019$735,00032,2890.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Skorpios Trust 3,271,829$125,180,17850.58%
COMMODORE CAPITAL LP 790,000$30,225,4004.60%
Redmile Group, LLC 2,044,389$78,218,3233.39%
SILVERARC CAPITAL MANAGEMENT, LLC 202,561$7,749,9843.20%
Ghost Tree Capital, LLC 275,000$10,522,0003.11%
Avidity Partners Management LP 2,447,000$93,622,2203.11%
Atlas Venture Life Science Advisors, LLC 594,251$22,736,0433.08%
Logos Global Management LP 400,000$15,304,0002.19%
Yiheng Capital Management, L.P. 1,125,791$43,072,7641.70%
Boxer Capital, LLC 831,495$31,8131.56%
View complete list of AKERO THERAPEUTICS INC shareholders